Biochemical Engineering Special Interest Group
biological engineering professionals
02 August 2017

TC BioPharm Wins $4.7M in EU Horizon 2020 Funding

TC BioPharm (TCB) said today it has won a €4 million ($4.7 million) grant from the European Union's Horizon 2020 (H2020) research and innovation program to advance its gamma-delta T (GDT) cell therapy for cancer. TCB said the H2020 grant will allow it to develop a next-generation GDT cell therapy, OmnImmune®, using an allogeneic approach, in which treatments can be manufactured using existing donor cells stored in a biobank. Source: Genetic Engineering News 2/8/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).